Perceptive Advisors’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Perceptive Advisors’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-744,056	Closed	-$46.3M	–	129
2023 Q4	$46.3M	Sell	744,056 -32,749	-4%	-$814K	1.03%	30
2023 Q3	$17.2M	Buy	+776,805	New	+$16.3M	0.58%	48

Perceptive Advisors's RYZB Position: Q1 2024 in Review

Perceptive Advisors sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 744,056 shares — an estimated $46.3M sold.

Perceptive Advisors first reported a position in RYZB in Q3 2023 and held it in 2 quarters. The position peaked at $46.3M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

Perceptive Advisors reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Perceptive Advisors sold 744,056 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $46.3M.
Perceptive Advisors first reported a position in RayzeBio, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
Perceptive Advisors's RayzeBio, Inc. Common Stock position peaked at $46.3M in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Perceptive Advisors's 13F filing for Q1 2024, filed 15 May 2024.